Effect of clomiphene citrate on ovarian, endometrial, and cervical histologies in a rat model

Gynecologic and Obstetric Investigation

Volumn 60, Issue 4, 2005, Pages 181-185

  Ozdemir, Ismail ^a   Ustundag, Nil ^a   Guven, Aysel ^a   Duran, Bulent ^b   Demirci, Fuat ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Clomiphene citrate; Endometrial histology; Ovarian histology; Rat model

Indexed keywords

CLOMIFENE CITRATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ENDOMETRIUM; FEMALE; GRANULOSA CELL; HISTOPATHOLOGY; LUTEAL CELL; MITOSIS; NONHUMAN; OVARY; OVARY FOLLICLE CELL; PRIORITY JOURNAL; RANDOMIZATION; RAT; THECA CELL; UTERINE CERVIX;

ANIMALS; CERVIX UTERI; CLOMIPHENE; CORPUS LUTEUM; ENDOMETRIUM; FEMALE; GRANULOSA CELLS; OVARIAN FOLLICLE; OVARIAN NEOPLASMS; OVARY; RATS; RATS, WISTAR; THECA CELLS;

EID: 27644547331     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086962     Document Type: Article

References (19)

1. Jordan VC, Gottardis MM, Satyaswaroop PG: Tamoxifen-stimulated growth of human endometrial carcinoma. Ann NY Acad Sci 1991;622:439-446.
2. Malfetano JH: Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients. Gynecol Oncol 1990;39:82-84.
3. van Leeuwen FE, Benraadt J, Coebergh JW, Kiemeney LA, Gimbrere CH, Otter R, Schouten LJ, Damhuis RA, Bontenbal M, Diepenhorst FW: Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994;343:448-452.
4. Kedar RP, Bourne TH, Powles TJ, Collins WP, Ashley SE, Cosgrove DO, Campbell S: Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 1994;343:1318-1321.
5. Whittemore AS, Harris R, Intyre J: Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1184-1203.
6. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG: Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-776.
7. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG: Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996;65:13-18.
8. Venn A, Watson L, Lumley J, Giles G, King C, Healy D: Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995;346:995-1000.
9. Franceschi S, La Vecchia C, Negri E, Guarneri S, Montella M, Conti E, Parazzini F: Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 1994;9:1673-1675.
10. Bristow RE, Karlan BY: Ovulation induction, infertility, and ovarian cancer risk. Fertil Steril 1996;66:499-507.
11. Modan B, Ron E, Lerner-Geva L, Blumstein T, Menczer J, Rabinovici J, Oelsner G, Freedman L, Mashiach S, Lunenfeld B: Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998;147:1038-1042.
12. Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL: Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 2004;103:1194-1203.
13. Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN: Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 1997;67:1005-1012.
14. Potashnik G, Lerner-Geva L, Genkin L, Chetrit A, Lunenfeld E, Porath A: Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 1999;71:853-859.
15. Unkila-Kallio L, Leminen A, Tiitinen A, Ylikorkala O: Nationwide data on falling incidence of ovarian granulosa cell tumours concomitant with increasing use of ovulation inducers. Hum Reprod 1998;13:2828-2830.
16. Gocze P, Krommer K, Csermely T, Cziraky K, Garamvolgyi Z, Kovacs K, Szabo I: Ovulation induction therapy and malignant ovarian cancer. Orv Hetil 2000;141:71-75.
17. Willemsen W, Kruitwagen R, Bastiaans B, Hanselaar T, Rolland R: Ovarian stimulation and granulosa-cell tumour. Lancet 1993;341:986-988.
18. Rao AR: Effects of carcinogen and/or mutagen on normal and gonatotropin-primed ovaries of mice. Int J Cancer 1981;28:105-110.
19. Bengtsson M, Hamberger L, Rydstrom J: Metabolism of 7,12-dimethylbenz(a) anthracene by different types of cells in the human ovary. Xenobiotica 1988;18:1255-1270.